XIDX
VICI
Market cap233mUSD
Nov 12, Last price
630.00IDR
Name
Victoria Care Indonesia Tbk PT
Chart & Performance
P/E
30.91
P/S
3.00
EPS
20.38
Div Yield, %
1.11%
Shrs. gr., 5y
—
Rev. gr., 5y
6.16%
Revenues
1.41t
+0.47%
Net income
136.74b
-22.28%
CFO
177.58b
+23.11%
Dividend
Sep 18, 20253 IDR/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
PT Victoria Care Indonesia Tbk, an Indonesian company established in 1988 with its headquarters in Jakarta Barat, specializes in the manufacturing and distribution of beauty and personal hygiene items. The firm's business activities are categorized into three primary divisions. The Personal Care and Antiseptic segment encompasses a broad spectrum of skincare, makeup, and body care products, including lotions, creams, scrubs, soaps, perfumes, and deodorants, alongside various antiseptic formulations such as liquids, gels, soaps, cleaning fluids, and disinfectants. The Hair Care division focuses on products for hair maintenance and styling, offering items like shampoos, masks, colorants, and agents for perming or straightening. A third, "Others," segment diversifies the company's portfolio with offerings like coffee (in both powder and bean forms), souvenirs, and snack foods. The company markets its extensive product range under several well-known brands, including Miranda, Herborist, Victoria, Nuface, CBD, Iria, and Sixsence. Beyond its domestic sales in Indonesia, PT Victoria Care Indonesia Tbk also engages in international trade, exporting its goods to countries such as Japan, China, Malaysia, Brunei Darussalam, and Hong Kong.
Valuation
Title IDR in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||